Asian stock markets declined Friday after Wall Street hit a new high on optimism about economic stimulus and coronavirus vaccine development despite a spike in US unemployment claims. Shanghai, Tokyo and Hong Kong retreated. Overnight, Wall Street's benchmark S&P 500 index gained for a third day on optimism about progress in Washington toward a new economic aid package while the government reported the highest level of new jobless claims in three months. Market action suggested investors see bad data is good news for progress toward a stimulus, said Mizuho Bank in a report. The Nikkei 225 in Tokyo lost 0.2% to 26,760.30 while the Shanghai Composite Index was down less than 0.1% at 3,403.87. The Hang Seng in Hong Kong lost 0.7% to 26,490.37. The Kospi in Seoul lost less than 0.1% to 2,770.22 and Sydney's S&P-ASX 200 sank 0.7% to 6,710.00. New Zealand, Singapore and Jakarta also retreated. Investors have been waiting since before the American presidential election Nov. 3 for ...
A financial analyst recently told that Pfizer's involvement in the coronavirus pandemic was about "as much public relations as it is a financial return
The US Food and Drug Administration's advisory panel, comprising external experts, has given an emergency use approval to Moderna Covid-19 vaccine
The overall number of global coronavirus cases has topped 74.8 million, while the deaths have surged to more than 1.66 million, according to the Johns Hopkins University
India recognised the Covid-19 threat early and pursued a scientific evidence-based approach to combat the situation, said Harsh Vardhan, Union Minister for Health
Logistical hurdles are a significant risk for efforts to rapidly distribute COVID-19 vaccines, but they have resulted in booming business for digital supply chain tracking companies
Many Indians appear hesitant to get vaccinated for Covid-19 as infections have fallen sharply since a mid-September peak and some people are worried about possible side-effects, according to a survey
India will have to spend $1.4 billion to $1.8 billion in the first phase of a coronavirus vaccination programme, even after getting support under the COVAX global vaccine-sharing scheme
Advice comes from Centre; some states begin talks with pharma firms
Patient had allergic reaction and is stable after night in hospital; delay in delivery adds to woes
Many have criticised the slow EU approval process for the approval of vaccines
Agency had forecast a small contraction of one per cent during Q3
The loan will support the pharmaceutical firm's expansion of low-priced, generic vaccines for routine immunisation of children and to boost capacity for manufacturing any future Covid-19 vaccine
Critical to the Covid-19 fight at community level, they remain undervalued and identified only as volunteers
Says Hero MotoCorp had the best ever month of October since it started in 1985 with highest production, dispatch and sales in a day
An FDA panel of outside advisers is weighing the safety and effectiveness of Moderna's vaccine candidate at a meeting on Thursday
The government is making all efforts to support and promote the development of vaccines for Covid-19, but there is a need to strengthen cold chain logistics
Pfizer has said its Covid-19 vaccine is being priced in a way that will help governments to ensure that there is little to no out-of-pocket costs
It is not clear what symptoms Macron was experiencing
The Russian-made vaccine has received a mixed response, with reports of empty Moscow clinics that offered the shot to health care workers and teachers